Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Identifieur interne : 000580 ( PubMed/Corpus ); précédent : 000579; suivant : 000581Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Auteurs : Warren Phipps ; Fred Ssewankambo ; Huong Nguyen ; Misty Saracino ; Anna Wald ; Lawrence Corey ; Jackson Orem ; Andrew Kambugu ; Corey CasperSource :
- PloS one [ 1932-6203 ] ; 2010.
English descriptors
- KwdEn :
- Adolescent, Adult, Anti-Retroviral Agents (therapeutic use), CD4 Lymphocyte Count, Epidemics, Female, HIV Infections (complications), HIV Infections (drug therapy), Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Multivariate Analysis, Outcome Assessment (Health Care) (statistics & numerical data), Proportional Hazards Models, Sarcoma, Kaposi (complications), Sarcoma, Kaposi (drug therapy), Sarcoma, Kaposi (epidemiology), Sex Factors, Uganda (epidemiology), Young Adult.
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic , epidemiology : Uganda.
- complications : HIV Infections, Sarcoma, Kaposi.
- drug therapy : HIV Infections, Sarcoma, Kaposi.
- epidemiology : Sarcoma, Kaposi.
- statistics & numerical data : Outcome Assessment (Health Care).
- Adolescent, Adult, CD4 Lymphocyte Count, Epidemics, Female, Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Multivariate Analysis, Proportional Hazards Models, Sex Factors, Young Adult.
Abstract
The incidence of Kaposi sarcoma (KS) has increased dramatically among women in sub-Saharan Africa since the onset of the HIV pandemic, but data on KS disease in women are limited. To identify gender-related differences in KS presentation and outcomes, we evaluated the clinical manifestations and response in men and women with AIDS-associated KS in Uganda.
DOI: 10.1371/journal.pone.0013936
PubMed: 21103057
Links to Exploration step
pubmed:21103057Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.</title><author><name sortKey="Phipps, Warren" sort="Phipps, Warren" uniqKey="Phipps W" first="Warren" last="Phipps">Warren Phipps</name><affiliation><nlm:affiliation>Department of Medicine, University of Washington, Seattle, Washington, United States of America. wtphipps@fhcrc.org</nlm:affiliation></affiliation></author><author><name sortKey="Ssewankambo, Fred" sort="Ssewankambo, Fred" uniqKey="Ssewankambo F" first="Fred" last="Ssewankambo">Fred Ssewankambo</name></author><author><name sortKey="Nguyen, Huong" sort="Nguyen, Huong" uniqKey="Nguyen H" first="Huong" last="Nguyen">Huong Nguyen</name></author><author><name sortKey="Saracino, Misty" sort="Saracino, Misty" uniqKey="Saracino M" first="Misty" last="Saracino">Misty Saracino</name></author><author><name sortKey="Wald, Anna" sort="Wald, Anna" uniqKey="Wald A" first="Anna" last="Wald">Anna Wald</name></author><author><name sortKey="Corey, Lawrence" sort="Corey, Lawrence" uniqKey="Corey L" first="Lawrence" last="Corey">Lawrence Corey</name></author><author><name sortKey="Orem, Jackson" sort="Orem, Jackson" uniqKey="Orem J" first="Jackson" last="Orem">Jackson Orem</name></author><author><name sortKey="Kambugu, Andrew" sort="Kambugu, Andrew" uniqKey="Kambugu A" first="Andrew" last="Kambugu">Andrew Kambugu</name></author><author><name sortKey="Casper, Corey" sort="Casper, Corey" uniqKey="Casper C" first="Corey" last="Casper">Corey Casper</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:21103057</idno><idno type="pmid">21103057</idno><idno type="doi">10.1371/journal.pone.0013936</idno><idno type="wicri:Area/PubMed/Corpus">000580</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000580</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.</title><author><name sortKey="Phipps, Warren" sort="Phipps, Warren" uniqKey="Phipps W" first="Warren" last="Phipps">Warren Phipps</name><affiliation><nlm:affiliation>Department of Medicine, University of Washington, Seattle, Washington, United States of America. wtphipps@fhcrc.org</nlm:affiliation></affiliation></author><author><name sortKey="Ssewankambo, Fred" sort="Ssewankambo, Fred" uniqKey="Ssewankambo F" first="Fred" last="Ssewankambo">Fred Ssewankambo</name></author><author><name sortKey="Nguyen, Huong" sort="Nguyen, Huong" uniqKey="Nguyen H" first="Huong" last="Nguyen">Huong Nguyen</name></author><author><name sortKey="Saracino, Misty" sort="Saracino, Misty" uniqKey="Saracino M" first="Misty" last="Saracino">Misty Saracino</name></author><author><name sortKey="Wald, Anna" sort="Wald, Anna" uniqKey="Wald A" first="Anna" last="Wald">Anna Wald</name></author><author><name sortKey="Corey, Lawrence" sort="Corey, Lawrence" uniqKey="Corey L" first="Lawrence" last="Corey">Lawrence Corey</name></author><author><name sortKey="Orem, Jackson" sort="Orem, Jackson" uniqKey="Orem J" first="Jackson" last="Orem">Jackson Orem</name></author><author><name sortKey="Kambugu, Andrew" sort="Kambugu, Andrew" uniqKey="Kambugu A" first="Andrew" last="Kambugu">Andrew Kambugu</name></author><author><name sortKey="Casper, Corey" sort="Casper, Corey" uniqKey="Casper C" first="Corey" last="Casper">Corey Casper</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>CD4 Lymphocyte Count</term><term>Epidemics</term><term>Female</term><term>HIV Infections (complications)</term><term>HIV Infections (drug therapy)</term><term>Humans</term><term>Incidence</term><term>Kaplan-Meier Estimate</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Outcome Assessment (Health Care) (statistics & numerical data)</term><term>Proportional Hazards Models</term><term>Sarcoma, Kaposi (complications)</term><term>Sarcoma, Kaposi (drug therapy)</term><term>Sarcoma, Kaposi (epidemiology)</term><term>Sex Factors</term><term>Uganda (epidemiology)</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Uganda</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Sarcoma, Kaposi</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term><term>Sarcoma, Kaposi</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Sarcoma, Kaposi</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Outcome Assessment (Health Care)</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>CD4 Lymphocyte Count</term><term>Epidemics</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Kaplan-Meier Estimate</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Proportional Hazards Models</term><term>Sex Factors</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The incidence of Kaposi sarcoma (KS) has increased dramatically among women in sub-Saharan Africa since the onset of the HIV pandemic, but data on KS disease in women are limited. To identify gender-related differences in KS presentation and outcomes, we evaluated the clinical manifestations and response in men and women with AIDS-associated KS in Uganda.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21103057</PMID><DateCreated><Year>2010</Year><Month>11</Month><Day>24</Day></DateCreated><DateCompleted><Year>2011</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>11</Issue><PubDate><Year>2010</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.</ArticleTitle><Pagination><MedlinePgn>e13936</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0013936</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The incidence of Kaposi sarcoma (KS) has increased dramatically among women in sub-Saharan Africa since the onset of the HIV pandemic, but data on KS disease in women are limited. To identify gender-related differences in KS presentation and outcomes, we evaluated the clinical manifestations and response in men and women with AIDS-associated KS in Uganda.</AbstractText><AbstractText Label="METHODS AND FINDINGS" NlmCategory="RESULTS">HIV-infected adults with KS attending the Infectious Diseases Institute (IDI) and Uganda Cancer Institute (UCI) in Kampala, Uganda between 2004 and 2006 were included in a retrospective cohort. Evaluation of KS presentation was based on the clinical features described at the initial KS visit. Response was evaluated as the time to "improvement", as defined by any decrease in lesion size, lesion number, or edema. The cohort consisted of 197 adults with HIV and KS: 55% (108/197) were women. At presentation, the median CD4 T-cell count was significantly lower in women (58 cells/mm(3); IQR 11-156 cells/mm(3)) than men (124 cells/mm(3); IQR 22-254 cells/mm(3)) (p = 0.02). Women were more likely than men to present with lesions of the face (OR 2.8, 95% CI, 1.4, 5.7; p = 0.005) and hard palate (OR 2.0, 95% CI, 1.1, 3.7; p = 0.02), and were less likely than men to have lower extremity lesions (OR 0.54, 95% CI, 0.3, 0.99; p = 0.05). Women were less likely than men to demonstrate clinical improvement (HR = 0.52, CI 0.31, 0.88; p = 0.01) in multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The clinical presentation and response of KS differs between men and women in Uganda. These data suggest that gender affects the pathophysiology of KS, which may have implications for the prevention, diagnosis, and treatment of KS in both men and women. Prospective studies are needed to identify predictors of response and evaluate efficacy of treatment in women with KS, particularly in Africa where the disease burden is greatest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phipps</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, Washington, United States of America. wtphipps@fhcrc.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ssewankambo</LastName><ForeName>Fred</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Huong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Saracino</LastName><ForeName>Misty</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Corey</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Orem</LastName><ForeName>Jackson</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kambugu</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Corey</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007140</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 A1071113</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Jul 31;21(12):1541-5</RefSource><PMID Version="1">17630548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1998 Sep;34(10):1634-7</RefSource><PMID Version="1">9893642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1997 Jul;176(1):84-93</RefSource><PMID Version="1">9207353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1991 Jul;5(7):877-80</RefSource><PMID Version="1">1892593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):337-41</RefSource><PMID Version="1">10096577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(1):e4222</RefSource><PMID Version="1">19156206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2000 Jan 1;85(1):54-9</RefSource><PMID Version="1">10585583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1996 Sep;10(11):1221-5</RefSource><PMID Version="1">8883583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1996 Oct 24;335(17):1261-9</RefSource><PMID Version="1">8857005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253</RefSource><PMID Version="1">11234459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2004 Sep 3;18(13):1819-26</RefSource><PMID Version="1">15316343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>East Afr Med J. 2004 Mar;81(3):120-3</RefSource><PMID Version="1">15293968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Feb 15;118(4):985-90</RefSource><PMID Version="1">16106415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gend Med. 2007 Sep;4(3):266-73</RefSource><PMID Version="1">18022592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1997 Sep;15(9):3085-92</RefSource><PMID Version="1">9294471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):306-8</RefSource><PMID Version="1">17146369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2003 Jan 10;103(2):233-40</RefSource><PMID Version="1">12455038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Korean J Intern Med. 2005 Dec;20(4):290-4</RefSource><PMID Version="1">16491826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1989 Sep;7(9):1201-7</RefSource><PMID Version="1">2671281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1999 Dec 24;13(18):2563-70</RefSource><PMID Version="1">10630526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1995 May 4;375(6526):64-8</RefSource><PMID Version="1">7723844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):233-8</RefSource><PMID Version="1">15076237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 2003 Dec;131(3):1125-9</RefSource><PMID Version="1">14959780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Nov 21;347(21):1652-61</RefSource><PMID Version="1">12444179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1995 Sep 7;377(6544):21; author reply 22</RefSource><PMID Version="1">7659154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2005 Jan;99(1):81-91</RefSource><PMID Version="1">15701259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 2008 Jun;19(6):400-5</RefSource><PMID Version="1">18595878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dent Res. 2004 Aug;83(8):639-43</RefSource><PMID Version="1">15271974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1991 Apr;5(4):466-7</RefSource><PMID Version="1">1676286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2000 May;82(9):1585-92</RefSource><PMID Version="1">10789729</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment (Health Care)</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC2980479</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>04</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21103057</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0013936</ArticleId><ArticleId IdType="pmc">PMC2980479</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000580 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000580 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:21103057
|texte= Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:21103057" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |